nodes	percent_of_prediction	percent_of_DWPC	metapath
Delavirdine—CYP2D6—Fingolimod—multiple sclerosis	0.0909	0.148	CbGbCtD
Delavirdine—CYP3A4—Fingolimod—multiple sclerosis	0.0578	0.0939	CbGbCtD
Delavirdine—CYP3A7—Dexamethasone—multiple sclerosis	0.0482	0.0782	CbGbCtD
Delavirdine—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.0482	0.0782	CbGbCtD
Delavirdine—CYP2C19—Prednisone—multiple sclerosis	0.0467	0.0758	CbGbCtD
Delavirdine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0372	0.0605	CbGbCtD
Delavirdine—CYP3A5—Dexamethasone—multiple sclerosis	0.0361	0.0587	CbGbCtD
Delavirdine—CYP2C8—Dexamethasone—multiple sclerosis	0.0347	0.0564	CbGbCtD
Delavirdine—CYP2C19—Dexamethasone—multiple sclerosis	0.0291	0.0473	CbGbCtD
Delavirdine—CYP3A4—Triamcinolone—multiple sclerosis	0.0282	0.0459	CbGbCtD
Delavirdine—CYP3A4—Mitoxantrone—multiple sclerosis	0.0272	0.0441	CbGbCtD
Delavirdine—CYP2C9—Dexamethasone—multiple sclerosis	0.0242	0.0394	CbGbCtD
Delavirdine—CYP3A4—Betamethasone—multiple sclerosis	0.0242	0.0393	CbGbCtD
Delavirdine—CYP3A4—Prednisolone—multiple sclerosis	0.0239	0.0388	CbGbCtD
Delavirdine—CYP3A4—Prednisone—multiple sclerosis	0.0226	0.0367	CbGbCtD
Delavirdine—CYP2D6—Dexamethasone—multiple sclerosis	0.0222	0.036	CbGbCtD
Delavirdine—CYP3A4—Dexamethasone—multiple sclerosis	0.0141	0.0229	CbGbCtD
Delavirdine—CYP3A5—Irinotecan Pathway—BCHE—multiple sclerosis	0.000335	0.0207	CbGpPWpGaD
Delavirdine—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000333	0.0206	CbGpPWpGaD
Delavirdine—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000333	0.0206	CbGpPWpGaD
Delavirdine—CYP3A7—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000328	0.0203	CbGpPWpGaD
Delavirdine—CYP3A7—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000328	0.0203	CbGpPWpGaD
Delavirdine—CYP3A7—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00027	0.0167	CbGpPWpGaD
Delavirdine—CYP3A7—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.00027	0.0167	CbGpPWpGaD
Delavirdine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000267	0.0165	CbGpPWpGaD
Delavirdine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000267	0.0165	CbGpPWpGaD
Delavirdine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.00024	0.0149	CbGpPWpGaD
Delavirdine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.00024	0.0149	CbGpPWpGaD
Delavirdine—CYP3A5—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000237	0.0147	CbGpPWpGaD
Delavirdine—CYP3A5—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000237	0.0147	CbGpPWpGaD
Delavirdine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000228	0.0141	CbGpPWpGaD
Delavirdine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000228	0.0141	CbGpPWpGaD
Delavirdine—Angioedema—Dexamethasone—multiple sclerosis	0.000218	0.000593	CcSEcCtD
Delavirdine—Stomatitis—Methotrexate—multiple sclerosis	0.000217	0.000589	CcSEcCtD
Delavirdine—Conjunctivitis—Methotrexate—multiple sclerosis	0.000216	0.000588	CcSEcCtD
Delavirdine—Confusional state—Methylprednisolone—multiple sclerosis	0.000216	0.000587	CcSEcCtD
Delavirdine—Malaise—Betamethasone—multiple sclerosis	0.000216	0.000585	CcSEcCtD
Delavirdine—Malaise—Dexamethasone—multiple sclerosis	0.000216	0.000585	CcSEcCtD
Delavirdine—Oedema—Triamcinolone—multiple sclerosis	0.000215	0.000584	CcSEcCtD
Delavirdine—Vertigo—Betamethasone—multiple sclerosis	0.000215	0.000583	CcSEcCtD
Delavirdine—Vertigo—Dexamethasone—multiple sclerosis	0.000215	0.000583	CcSEcCtD
Delavirdine—Syncope—Dexamethasone—multiple sclerosis	0.000214	0.000582	CcSEcCtD
Delavirdine—Syncope—Betamethasone—multiple sclerosis	0.000214	0.000582	CcSEcCtD
Delavirdine—Infection—Triamcinolone—multiple sclerosis	0.000214	0.00058	CcSEcCtD
Delavirdine—Infection—Methylprednisolone—multiple sclerosis	0.000213	0.000579	CcSEcCtD
Delavirdine—Haematuria—Methotrexate—multiple sclerosis	0.000212	0.000576	CcSEcCtD
Delavirdine—Shock—Triamcinolone—multiple sclerosis	0.000212	0.000575	CcSEcCtD
Delavirdine—Insomnia—Prednisolone—multiple sclerosis	0.000212	0.000574	CcSEcCtD
Delavirdine—Alopecia—Prednisone—multiple sclerosis	0.000211	0.000574	CcSEcCtD
Delavirdine—Shock—Methylprednisolone—multiple sclerosis	0.000211	0.000573	CcSEcCtD
Delavirdine—Loss of consciousness—Dexamethasone—multiple sclerosis	0.00021	0.000571	CcSEcCtD
Delavirdine—Loss of consciousness—Betamethasone—multiple sclerosis	0.00021	0.000571	CcSEcCtD
Delavirdine—Epistaxis—Methotrexate—multiple sclerosis	0.00021	0.00057	CcSEcCtD
Delavirdine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00021	0.00057	CcSEcCtD
Delavirdine—Paraesthesia—Prednisolone—multiple sclerosis	0.00021	0.00057	CcSEcCtD
Delavirdine—Tachycardia—Triamcinolone—multiple sclerosis	0.00021	0.00057	CcSEcCtD
Delavirdine—Nausea—Azathioprine—multiple sclerosis	0.000209	0.000569	CcSEcCtD
Delavirdine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000209	0.000569	CcSEcCtD
Delavirdine—Skin disorder—Methylprednisolone—multiple sclerosis	0.000208	0.000566	CcSEcCtD
Delavirdine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000208	0.0129	CbGpPWpGaD
Delavirdine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000208	0.0129	CbGpPWpGaD
Delavirdine—Malnutrition—Prednisone—multiple sclerosis	0.000208	0.000565	CcSEcCtD
Delavirdine—Erythema—Prednisone—multiple sclerosis	0.000208	0.000565	CcSEcCtD
Delavirdine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000208	0.000565	CcSEcCtD
Delavirdine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000207	0.000563	CcSEcCtD
Delavirdine—Hypertension—Betamethasone—multiple sclerosis	0.000206	0.000561	CcSEcCtD
Delavirdine—Hypertension—Dexamethasone—multiple sclerosis	0.000206	0.000561	CcSEcCtD
Delavirdine—CYP2C8—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000206	0.0127	CbGpPWpGaD
Delavirdine—CYP2C8—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000206	0.0127	CbGpPWpGaD
Delavirdine—Asthenia—Mitoxantrone—multiple sclerosis	0.000205	0.000555	CcSEcCtD
Delavirdine—Myalgia—Dexamethasone—multiple sclerosis	0.000204	0.000553	CcSEcCtD
Delavirdine—Myalgia—Betamethasone—multiple sclerosis	0.000204	0.000553	CcSEcCtD
Delavirdine—Anxiety—Betamethasone—multiple sclerosis	0.000203	0.000551	CcSEcCtD
Delavirdine—Anxiety—Dexamethasone—multiple sclerosis	0.000203	0.000551	CcSEcCtD
Delavirdine—Discomfort—Dexamethasone—multiple sclerosis	0.000201	0.000546	CcSEcCtD
Delavirdine—Discomfort—Betamethasone—multiple sclerosis	0.000201	0.000546	CcSEcCtD
Delavirdine—Hypotension—Methylprednisolone—multiple sclerosis	0.000201	0.000544	CcSEcCtD
Delavirdine—Pain—Prednisolone—multiple sclerosis	0.0002	0.000543	CcSEcCtD
Delavirdine—Hepatitis—Methotrexate—multiple sclerosis	0.0002	0.000543	CcSEcCtD
Delavirdine—Pharyngitis—Methotrexate—multiple sclerosis	0.000198	0.000539	CcSEcCtD
Delavirdine—Vision blurred—Prednisone—multiple sclerosis	0.000196	0.000533	CcSEcCtD
Delavirdine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000196	0.000532	CcSEcCtD
Delavirdine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000196	0.000531	CcSEcCtD
Delavirdine—Oedema—Dexamethasone—multiple sclerosis	0.000195	0.00053	CcSEcCtD
Delavirdine—Oedema—Betamethasone—multiple sclerosis	0.000195	0.00053	CcSEcCtD
Delavirdine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000195	0.00053	CcSEcCtD
Delavirdine—CYP3A5—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000195	0.0121	CbGpPWpGaD
Delavirdine—CYP3A5—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000195	0.0121	CbGpPWpGaD
Delavirdine—Insomnia—Triamcinolone—multiple sclerosis	0.000195	0.000528	CcSEcCtD
Delavirdine—Insomnia—Methylprednisolone—multiple sclerosis	0.000194	0.000527	CcSEcCtD
Delavirdine—Infection—Betamethasone—multiple sclerosis	0.000194	0.000526	CcSEcCtD
Delavirdine—Infection—Dexamethasone—multiple sclerosis	0.000194	0.000526	CcSEcCtD
Delavirdine—Ill-defined disorder—Prednisone—multiple sclerosis	0.000193	0.000525	CcSEcCtD
Delavirdine—Paraesthesia—Triamcinolone—multiple sclerosis	0.000193	0.000524	CcSEcCtD
Delavirdine—Feeling abnormal—Prednisolone—multiple sclerosis	0.000193	0.000523	CcSEcCtD
Delavirdine—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000193	0.000523	CcSEcCtD
Delavirdine—Anaemia—Prednisone—multiple sclerosis	0.000192	0.000523	CcSEcCtD
Delavirdine—Shock—Betamethasone—multiple sclerosis	0.000192	0.000521	CcSEcCtD
Delavirdine—Shock—Dexamethasone—multiple sclerosis	0.000192	0.000521	CcSEcCtD
Delavirdine—Dyspnoea—Triamcinolone—multiple sclerosis	0.000192	0.000521	CcSEcCtD
Delavirdine—Agitation—Prednisone—multiple sclerosis	0.000191	0.00052	CcSEcCtD
Delavirdine—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000191	0.000519	CcSEcCtD
Delavirdine—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000191	0.000519	CcSEcCtD
Delavirdine—Tachycardia—Dexamethasone—multiple sclerosis	0.00019	0.000517	CcSEcCtD
Delavirdine—Tachycardia—Betamethasone—multiple sclerosis	0.00019	0.000517	CcSEcCtD
Delavirdine—Angioedema—Prednisone—multiple sclerosis	0.00019	0.000517	CcSEcCtD
Delavirdine—Dyspepsia—Triamcinolone—multiple sclerosis	0.000189	0.000514	CcSEcCtD
Delavirdine—Erythema multiforme—Methotrexate—multiple sclerosis	0.000189	0.000513	CcSEcCtD
Delavirdine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000189	0.000513	CcSEcCtD
Delavirdine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000189	0.000512	CcSEcCtD
Delavirdine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000189	0.000512	CcSEcCtD
Delavirdine—Malaise—Prednisone—multiple sclerosis	0.000188	0.00051	CcSEcCtD
Delavirdine—Vertigo—Prednisone—multiple sclerosis	0.000187	0.000508	CcSEcCtD
Delavirdine—Syncope—Prednisone—multiple sclerosis	0.000187	0.000507	CcSEcCtD
Delavirdine—Tinnitus—Methotrexate—multiple sclerosis	0.000186	0.000506	CcSEcCtD
Delavirdine—Anorexia—Dexamethasone—multiple sclerosis	0.000186	0.000505	CcSEcCtD
Delavirdine—Anorexia—Betamethasone—multiple sclerosis	0.000186	0.000505	CcSEcCtD
Delavirdine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000186	0.0115	CbGpPWpGaD
Delavirdine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000186	0.0115	CbGpPWpGaD
Delavirdine—Urticaria—Prednisolone—multiple sclerosis	0.000186	0.000504	CcSEcCtD
Delavirdine—Fatigue—Triamcinolone—multiple sclerosis	0.000185	0.000503	CcSEcCtD
Delavirdine—Fatigue—Methylprednisolone—multiple sclerosis	0.000185	0.000502	CcSEcCtD
Delavirdine—Pain—Triamcinolone—multiple sclerosis	0.000184	0.000499	CcSEcCtD
Delavirdine—CYP2C19—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000183	0.0113	CbGpPWpGaD
Delavirdine—CYP2C19—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000183	0.0113	CbGpPWpGaD
Delavirdine—Loss of consciousness—Prednisone—multiple sclerosis	0.000183	0.000497	CcSEcCtD
Delavirdine—Hypotension—Betamethasone—multiple sclerosis	0.000182	0.000495	CcSEcCtD
Delavirdine—Hypotension—Dexamethasone—multiple sclerosis	0.000182	0.000495	CcSEcCtD
Delavirdine—Vomiting—Mitoxantrone—multiple sclerosis	0.000181	0.000492	CcSEcCtD
Delavirdine—Hypertension—Prednisone—multiple sclerosis	0.00018	0.000488	CcSEcCtD
Delavirdine—Rash—Mitoxantrone—multiple sclerosis	0.00018	0.000488	CcSEcCtD
Delavirdine—Dermatitis—Mitoxantrone—multiple sclerosis	0.00018	0.000488	CcSEcCtD
Delavirdine—Chills—Methotrexate—multiple sclerosis	0.000179	0.000487	CcSEcCtD
Delavirdine—Headache—Mitoxantrone—multiple sclerosis	0.000179	0.000485	CcSEcCtD
Delavirdine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000178	0.000483	CcSEcCtD
Delavirdine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000178	0.000483	CcSEcCtD
Delavirdine—Arthralgia—Prednisone—multiple sclerosis	0.000177	0.000481	CcSEcCtD
Delavirdine—Myalgia—Prednisone—multiple sclerosis	0.000177	0.000481	CcSEcCtD
Delavirdine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000177	0.000481	CcSEcCtD
Delavirdine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000177	0.00048	CcSEcCtD
Delavirdine—Anxiety—Prednisone—multiple sclerosis	0.000177	0.00048	CcSEcCtD
Delavirdine—Alopecia—Methotrexate—multiple sclerosis	0.000177	0.00048	CcSEcCtD
Delavirdine—Insomnia—Dexamethasone—multiple sclerosis	0.000176	0.000479	CcSEcCtD
Delavirdine—Insomnia—Betamethasone—multiple sclerosis	0.000176	0.000479	CcSEcCtD
Delavirdine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000176	0.0109	CbGpPWpGaD
Delavirdine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000176	0.0109	CbGpPWpGaD
Delavirdine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000175	0.000476	CcSEcCtD
Delavirdine—Paraesthesia—Dexamethasone—multiple sclerosis	0.000175	0.000476	CcSEcCtD
Delavirdine—Paraesthesia—Betamethasone—multiple sclerosis	0.000175	0.000476	CcSEcCtD
Delavirdine—Discomfort—Prednisone—multiple sclerosis	0.000175	0.000476	CcSEcCtD
Delavirdine—Erythema—Methotrexate—multiple sclerosis	0.000174	0.000473	CcSEcCtD
Delavirdine—Malnutrition—Methotrexate—multiple sclerosis	0.000174	0.000473	CcSEcCtD
Delavirdine—Hypersensitivity—Prednisolone—multiple sclerosis	0.000172	0.000468	CcSEcCtD
Delavirdine—Dyspepsia—Betamethasone—multiple sclerosis	0.000172	0.000466	CcSEcCtD
Delavirdine—Dyspepsia—Dexamethasone—multiple sclerosis	0.000172	0.000466	CcSEcCtD
Delavirdine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000171	0.0106	CbGpPWpGaD
Delavirdine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000171	0.0106	CbGpPWpGaD
Delavirdine—Urticaria—Triamcinolone—multiple sclerosis	0.000171	0.000464	CcSEcCtD
Delavirdine—Urticaria—Methylprednisolone—multiple sclerosis	0.00017	0.000463	CcSEcCtD
Delavirdine—Dysgeusia—Methotrexate—multiple sclerosis	0.00017	0.000463	CcSEcCtD
Delavirdine—Body temperature increased—Triamcinolone—multiple sclerosis	0.00017	0.000462	CcSEcCtD
Delavirdine—Oedema—Prednisone—multiple sclerosis	0.00017	0.000461	CcSEcCtD
Delavirdine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.00017	0.000461	CcSEcCtD
Delavirdine—Decreased appetite—Dexamethasone—multiple sclerosis	0.00017	0.000461	CcSEcCtD
Delavirdine—Decreased appetite—Betamethasone—multiple sclerosis	0.00017	0.000461	CcSEcCtD
Delavirdine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.00017	0.0105	CbGpPWpGaD
Delavirdine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.00017	0.0105	CbGpPWpGaD
Delavirdine—Nausea—Mitoxantrone—multiple sclerosis	0.000169	0.00046	CcSEcCtD
Delavirdine—CYP2C8—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000169	0.0104	CbGpPWpGaD
Delavirdine—CYP2C8—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000169	0.0104	CbGpPWpGaD
Delavirdine—Infection—Prednisone—multiple sclerosis	0.000169	0.000458	CcSEcCtD
Delavirdine—CYP2D6—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000169	0.0104	CbGpPWpGaD
Delavirdine—CYP2D6—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000169	0.0104	CbGpPWpGaD
Delavirdine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000168	0.000457	CcSEcCtD
Delavirdine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000168	0.000457	CcSEcCtD
Delavirdine—Back pain—Methotrexate—multiple sclerosis	0.000168	0.000457	CcSEcCtD
Delavirdine—Fatigue—Dexamethasone—multiple sclerosis	0.000168	0.000457	CcSEcCtD
Delavirdine—Fatigue—Betamethasone—multiple sclerosis	0.000168	0.000457	CcSEcCtD
Delavirdine—CYP2C9—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000167	0.0103	CbGpPWpGaD
Delavirdine—CYP2C9—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000167	0.0103	CbGpPWpGaD
Delavirdine—Shock—Prednisone—multiple sclerosis	0.000167	0.000454	CcSEcCtD
Delavirdine—Pain—Betamethasone—multiple sclerosis	0.000167	0.000453	CcSEcCtD
Delavirdine—Pain—Dexamethasone—multiple sclerosis	0.000167	0.000453	CcSEcCtD
Delavirdine—Tachycardia—Prednisone—multiple sclerosis	0.000166	0.00045	CcSEcCtD
Delavirdine—Skin disorder—Prednisone—multiple sclerosis	0.000165	0.000448	CcSEcCtD
Delavirdine—Hyperhidrosis—Prednisone—multiple sclerosis	0.000164	0.000446	CcSEcCtD
Delavirdine—Vision blurred—Methotrexate—multiple sclerosis	0.000164	0.000445	CcSEcCtD
Delavirdine—Anorexia—Prednisone—multiple sclerosis	0.000162	0.00044	CcSEcCtD
Delavirdine—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000161	0.000438	CcSEcCtD
Delavirdine—Anaemia—Methotrexate—multiple sclerosis	0.000161	0.000437	CcSEcCtD
Delavirdine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000161	0.000437	CcSEcCtD
Delavirdine—Feeling abnormal—Betamethasone—multiple sclerosis	0.000161	0.000437	CcSEcCtD
Delavirdine—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.00016	0.000433	CcSEcCtD
Delavirdine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.00016	0.000433	CcSEcCtD
Delavirdine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000158	0.00043	CcSEcCtD
Delavirdine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000158	0.000429	CcSEcCtD
Delavirdine—Malaise—Methotrexate—multiple sclerosis	0.000157	0.000426	CcSEcCtD
Delavirdine—Vertigo—Methotrexate—multiple sclerosis	0.000156	0.000425	CcSEcCtD
Delavirdine—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000156	0.00964	CbGpPWpGaD
Delavirdine—Leukopenia—Methotrexate—multiple sclerosis	0.000156	0.000423	CcSEcCtD
Delavirdine—Urticaria—Betamethasone—multiple sclerosis	0.000155	0.000421	CcSEcCtD
Delavirdine—Urticaria—Dexamethasone—multiple sclerosis	0.000155	0.000421	CcSEcCtD
Delavirdine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000155	0.00042	CcSEcCtD
Delavirdine—Dizziness—Prednisolone—multiple sclerosis	0.000155	0.00042	CcSEcCtD
Delavirdine—Asthenia—Triamcinolone—multiple sclerosis	0.000154	0.000419	CcSEcCtD
Delavirdine—Abdominal pain—Betamethasone—multiple sclerosis	0.000154	0.000419	CcSEcCtD
Delavirdine—Body temperature increased—Betamethasone—multiple sclerosis	0.000154	0.000419	CcSEcCtD
Delavirdine—Body temperature increased—Dexamethasone—multiple sclerosis	0.000154	0.000419	CcSEcCtD
Delavirdine—Abdominal pain—Dexamethasone—multiple sclerosis	0.000154	0.000419	CcSEcCtD
Delavirdine—Asthenia—Methylprednisolone—multiple sclerosis	0.000154	0.000418	CcSEcCtD
Delavirdine—Insomnia—Prednisone—multiple sclerosis	0.000154	0.000417	CcSEcCtD
Delavirdine—Paraesthesia—Prednisone—multiple sclerosis	0.000153	0.000414	CcSEcCtD
Delavirdine—Pruritus—Triamcinolone—multiple sclerosis	0.000152	0.000413	CcSEcCtD
Delavirdine—Cough—Methotrexate—multiple sclerosis	0.000152	0.000412	CcSEcCtD
Delavirdine—Pruritus—Methylprednisolone—multiple sclerosis	0.000152	0.000412	CcSEcCtD
Delavirdine—CYP2C19—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000151	0.00932	CbGpPWpGaD
Delavirdine—CYP2C19—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000151	0.00932	CbGpPWpGaD
Delavirdine—Dyspepsia—Prednisone—multiple sclerosis	0.00015	0.000406	CcSEcCtD
Delavirdine—Chest pain—Methotrexate—multiple sclerosis	0.000148	0.000402	CcSEcCtD
Delavirdine—Myalgia—Methotrexate—multiple sclerosis	0.000148	0.000402	CcSEcCtD
Delavirdine—Arthralgia—Methotrexate—multiple sclerosis	0.000148	0.000402	CcSEcCtD
Delavirdine—Decreased appetite—Prednisone—multiple sclerosis	0.000148	0.000401	CcSEcCtD
Delavirdine—Rash—Prednisolone—multiple sclerosis	0.000147	0.0004	CcSEcCtD
Delavirdine—Dermatitis—Prednisolone—multiple sclerosis	0.000147	0.0004	CcSEcCtD
Delavirdine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000147	0.000399	CcSEcCtD
Delavirdine—Fatigue—Prednisone—multiple sclerosis	0.000147	0.000398	CcSEcCtD
Delavirdine—Headache—Prednisolone—multiple sclerosis	0.000147	0.000398	CcSEcCtD
Delavirdine—Discomfort—Methotrexate—multiple sclerosis	0.000146	0.000397	CcSEcCtD
Delavirdine—Constipation—Prednisone—multiple sclerosis	0.000145	0.000395	CcSEcCtD
Delavirdine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000145	0.00896	CbGpPWpGaD
Delavirdine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000145	0.00896	CbGpPWpGaD
Delavirdine—CYP3A7—Biological oxidations—CYP27B1—multiple sclerosis	0.000143	0.00886	CbGpPWpGaD
Delavirdine—CYP3A7—Biological oxidations—CYP24A1—multiple sclerosis	0.000143	0.00886	CbGpPWpGaD
Delavirdine—Confusional state—Methotrexate—multiple sclerosis	0.000143	0.000389	CcSEcCtD
Delavirdine—CYP1A2—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000143	0.00884	CbGpPWpGaD
Delavirdine—CYP1A2—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000143	0.00884	CbGpPWpGaD
Delavirdine—Dizziness—Triamcinolone—multiple sclerosis	0.000142	0.000386	CcSEcCtD
Delavirdine—Dizziness—Methylprednisolone—multiple sclerosis	0.000142	0.000385	CcSEcCtD
Delavirdine—CYP3A7—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000141	0.00874	CbGpPWpGaD
Delavirdine—CYP3A7—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000141	0.00874	CbGpPWpGaD
Delavirdine—Infection—Methotrexate—multiple sclerosis	0.000141	0.000383	CcSEcCtD
Delavirdine—Feeling abnormal—Prednisone—multiple sclerosis	0.00014	0.00038	CcSEcCtD
Delavirdine—Asthenia—Betamethasone—multiple sclerosis	0.00014	0.00038	CcSEcCtD
Delavirdine—Asthenia—Dexamethasone—multiple sclerosis	0.00014	0.00038	CcSEcCtD
Delavirdine—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000139	0.000378	CcSEcCtD
Delavirdine—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000139	0.000377	CcSEcCtD
Delavirdine—Nausea—Prednisolone—multiple sclerosis	0.000139	0.000377	CcSEcCtD
Delavirdine—CYP2D6—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000139	0.00858	CbGpPWpGaD
Delavirdine—CYP2D6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000139	0.00858	CbGpPWpGaD
Delavirdine—Pruritus—Dexamethasone—multiple sclerosis	0.000138	0.000375	CcSEcCtD
Delavirdine—Pruritus—Betamethasone—multiple sclerosis	0.000138	0.000375	CcSEcCtD
Delavirdine—Skin disorder—Methotrexate—multiple sclerosis	0.000138	0.000375	CcSEcCtD
Delavirdine—CYP2C9—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000137	0.0085	CbGpPWpGaD
Delavirdine—CYP2C9—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000137	0.0085	CbGpPWpGaD
Delavirdine—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000137	0.000373	CcSEcCtD
Delavirdine—Vomiting—Triamcinolone—multiple sclerosis	0.000137	0.000371	CcSEcCtD
Delavirdine—Vomiting—Methylprednisolone—multiple sclerosis	0.000136	0.00037	CcSEcCtD
Delavirdine—Rash—Triamcinolone—multiple sclerosis	0.000136	0.000368	CcSEcCtD
Delavirdine—Dermatitis—Triamcinolone—multiple sclerosis	0.000135	0.000368	CcSEcCtD
Delavirdine—Anorexia—Methotrexate—multiple sclerosis	0.000135	0.000368	CcSEcCtD
Delavirdine—Rash—Methylprednisolone—multiple sclerosis	0.000135	0.000367	CcSEcCtD
Delavirdine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000135	0.000367	CcSEcCtD
Delavirdine—Urticaria—Prednisone—multiple sclerosis	0.000135	0.000367	CcSEcCtD
Delavirdine—Headache—Triamcinolone—multiple sclerosis	0.000135	0.000366	CcSEcCtD
Delavirdine—Headache—Methylprednisolone—multiple sclerosis	0.000134	0.000365	CcSEcCtD
Delavirdine—Abdominal pain—Prednisone—multiple sclerosis	0.000134	0.000365	CcSEcCtD
Delavirdine—Body temperature increased—Prednisone—multiple sclerosis	0.000134	0.000365	CcSEcCtD
Delavirdine—Diarrhoea—Betamethasone—multiple sclerosis	0.000134	0.000363	CcSEcCtD
Delavirdine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000134	0.000363	CcSEcCtD
Delavirdine—Hypotension—Methotrexate—multiple sclerosis	0.000133	0.00036	CcSEcCtD
Delavirdine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000129	0.000351	CcSEcCtD
Delavirdine—Dizziness—Dexamethasone—multiple sclerosis	0.000129	0.00035	CcSEcCtD
Delavirdine—Dizziness—Betamethasone—multiple sclerosis	0.000129	0.00035	CcSEcCtD
Delavirdine—Insomnia—Methotrexate—multiple sclerosis	0.000128	0.000349	CcSEcCtD
Delavirdine—Nausea—Triamcinolone—multiple sclerosis	0.000128	0.000347	CcSEcCtD
Delavirdine—Paraesthesia—Methotrexate—multiple sclerosis	0.000128	0.000346	CcSEcCtD
Delavirdine—Nausea—Methylprednisolone—multiple sclerosis	0.000127	0.000346	CcSEcCtD
Delavirdine—Dyspnoea—Methotrexate—multiple sclerosis	0.000127	0.000344	CcSEcCtD
Delavirdine—Somnolence—Methotrexate—multiple sclerosis	0.000126	0.000343	CcSEcCtD
Delavirdine—Hypersensitivity—Prednisone—multiple sclerosis	0.000125	0.00034	CcSEcCtD
Delavirdine—Dyspepsia—Methotrexate—multiple sclerosis	0.000125	0.000339	CcSEcCtD
Delavirdine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—multiple sclerosis	0.000124	0.00768	CbGpPWpGaD
Delavirdine—Vomiting—Dexamethasone—multiple sclerosis	0.000124	0.000337	CcSEcCtD
Delavirdine—Vomiting—Betamethasone—multiple sclerosis	0.000124	0.000337	CcSEcCtD
Delavirdine—Decreased appetite—Methotrexate—multiple sclerosis	0.000123	0.000335	CcSEcCtD
Delavirdine—Rash—Betamethasone—multiple sclerosis	0.000123	0.000334	CcSEcCtD
Delavirdine—Rash—Dexamethasone—multiple sclerosis	0.000123	0.000334	CcSEcCtD
Delavirdine—Dermatitis—Betamethasone—multiple sclerosis	0.000123	0.000334	CcSEcCtD
Delavirdine—Dermatitis—Dexamethasone—multiple sclerosis	0.000123	0.000334	CcSEcCtD
Delavirdine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000123	0.000333	CcSEcCtD
Delavirdine—Fatigue—Methotrexate—multiple sclerosis	0.000122	0.000332	CcSEcCtD
Delavirdine—Headache—Betamethasone—multiple sclerosis	0.000122	0.000332	CcSEcCtD
Delavirdine—Headache—Dexamethasone—multiple sclerosis	0.000122	0.000332	CcSEcCtD
Delavirdine—Asthenia—Prednisone—multiple sclerosis	0.000122	0.000331	CcSEcCtD
Delavirdine—Pain—Methotrexate—multiple sclerosis	0.000121	0.00033	CcSEcCtD
Delavirdine—Pruritus—Prednisone—multiple sclerosis	0.00012	0.000326	CcSEcCtD
Delavirdine—CYP1A2—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000117	0.00726	CbGpPWpGaD
Delavirdine—CYP1A2—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000117	0.00726	CbGpPWpGaD
Delavirdine—Feeling abnormal—Methotrexate—multiple sclerosis	0.000117	0.000318	CcSEcCtD
Delavirdine—Diarrhoea—Prednisone—multiple sclerosis	0.000116	0.000316	CcSEcCtD
Delavirdine—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000116	0.000315	CcSEcCtD
Delavirdine—Nausea—Betamethasone—multiple sclerosis	0.000116	0.000315	CcSEcCtD
Delavirdine—Nausea—Dexamethasone—multiple sclerosis	0.000116	0.000315	CcSEcCtD
Delavirdine—Urticaria—Methotrexate—multiple sclerosis	0.000113	0.000306	CcSEcCtD
Delavirdine—Dizziness—Prednisone—multiple sclerosis	0.000112	0.000305	CcSEcCtD
Delavirdine—Abdominal pain—Methotrexate—multiple sclerosis	0.000112	0.000305	CcSEcCtD
Delavirdine—Body temperature increased—Methotrexate—multiple sclerosis	0.000112	0.000305	CcSEcCtD
Delavirdine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000112	0.00692	CbGpPWpGaD
Delavirdine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000112	0.00692	CbGpPWpGaD
Delavirdine—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.00011	0.00683	CbGpPWpGaD
Delavirdine—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.00011	0.00683	CbGpPWpGaD
Delavirdine—Vomiting—Prednisone—multiple sclerosis	0.000108	0.000293	CcSEcCtD
Delavirdine—Rash—Prednisone—multiple sclerosis	0.000107	0.000291	CcSEcCtD
Delavirdine—Dermatitis—Prednisone—multiple sclerosis	0.000107	0.000291	CcSEcCtD
Delavirdine—Headache—Prednisone—multiple sclerosis	0.000106	0.000289	CcSEcCtD
Delavirdine—Hypersensitivity—Methotrexate—multiple sclerosis	0.000105	0.000284	CcSEcCtD
Delavirdine—CYP3A5—Biological oxidations—CYP27B1—multiple sclerosis	0.000104	0.00641	CbGpPWpGaD
Delavirdine—CYP3A5—Biological oxidations—CYP24A1—multiple sclerosis	0.000104	0.00641	CbGpPWpGaD
Delavirdine—CYP3A5—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000102	0.00632	CbGpPWpGaD
Delavirdine—CYP3A5—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000102	0.00632	CbGpPWpGaD
Delavirdine—Asthenia—Methotrexate—multiple sclerosis	0.000102	0.000277	CcSEcCtD
Delavirdine—Nausea—Prednisone—multiple sclerosis	0.000101	0.000274	CcSEcCtD
Delavirdine—Pruritus—Methotrexate—multiple sclerosis	0.0001	0.000273	CcSEcCtD
Delavirdine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.0001	0.00621	CbGpPWpGaD
Delavirdine—Diarrhoea—Methotrexate—multiple sclerosis	9.72e-05	0.000264	CcSEcCtD
Delavirdine—Dizziness—Methotrexate—multiple sclerosis	9.39e-05	0.000255	CcSEcCtD
Delavirdine—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	9.06e-05	0.00561	CbGpPWpGaD
Delavirdine—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	9.06e-05	0.00561	CbGpPWpGaD
Delavirdine—Vomiting—Methotrexate—multiple sclerosis	9.03e-05	0.000245	CcSEcCtD
Delavirdine—CYP2C8—Biological oxidations—CYP27B1—multiple sclerosis	8.97e-05	0.00555	CbGpPWpGaD
Delavirdine—CYP2C8—Biological oxidations—CYP24A1—multiple sclerosis	8.97e-05	0.00555	CbGpPWpGaD
Delavirdine—Rash—Methotrexate—multiple sclerosis	8.95e-05	0.000243	CcSEcCtD
Delavirdine—Dermatitis—Methotrexate—multiple sclerosis	8.95e-05	0.000243	CcSEcCtD
Delavirdine—Headache—Methotrexate—multiple sclerosis	8.9e-05	0.000242	CcSEcCtD
Delavirdine—CYP2C8—Metapathway biotransformation—CYP24A1—multiple sclerosis	8.85e-05	0.00547	CbGpPWpGaD
Delavirdine—CYP2C8—Metapathway biotransformation—CYP27B1—multiple sclerosis	8.85e-05	0.00547	CbGpPWpGaD
Delavirdine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	8.74e-05	0.0054	CbGpPWpGaD
Delavirdine—CYP2C19—Melatonin metabolism and effects—APOE—multiple sclerosis	8.71e-05	0.00539	CbGpPWpGaD
Delavirdine—Nausea—Methotrexate—multiple sclerosis	8.44e-05	0.000229	CcSEcCtD
Delavirdine—CYP2D6—Melatonin metabolism and effects—APOE—multiple sclerosis	8.01e-05	0.00496	CbGpPWpGaD
Delavirdine—CYP2C19—Biological oxidations—CYP24A1—multiple sclerosis	8.01e-05	0.00495	CbGpPWpGaD
Delavirdine—CYP2C19—Biological oxidations—CYP27B1—multiple sclerosis	8.01e-05	0.00495	CbGpPWpGaD
Delavirdine—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	7.9e-05	0.00488	CbGpPWpGaD
Delavirdine—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	7.9e-05	0.00488	CbGpPWpGaD
Delavirdine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	7.8e-05	0.00482	CbGpPWpGaD
Delavirdine—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.48e-05	0.00463	CbGpPWpGaD
Delavirdine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	7.47e-05	0.00462	CbGpPWpGaD
Delavirdine—CYP2D6—Biological oxidations—CYP24A1—multiple sclerosis	7.36e-05	0.00456	CbGpPWpGaD
Delavirdine—CYP2D6—Biological oxidations—CYP27B1—multiple sclerosis	7.36e-05	0.00456	CbGpPWpGaD
Delavirdine—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	7.3e-05	0.00452	CbGpPWpGaD
Delavirdine—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	7.3e-05	0.00452	CbGpPWpGaD
Delavirdine—CYP2D6—Metapathway biotransformation—CYP27B1—multiple sclerosis	7.26e-05	0.00449	CbGpPWpGaD
Delavirdine—CYP2D6—Metapathway biotransformation—CYP24A1—multiple sclerosis	7.26e-05	0.00449	CbGpPWpGaD
Delavirdine—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	7.2e-05	0.00445	CbGpPWpGaD
Delavirdine—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	7.2e-05	0.00445	CbGpPWpGaD
Delavirdine—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	6.89e-05	0.00426	CbGpPWpGaD
Delavirdine—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	6.79e-05	0.0042	CbGpPWpGaD
Delavirdine—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	6.24e-05	0.00386	CbGpPWpGaD
Delavirdine—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	6.24e-05	0.00386	CbGpPWpGaD
Delavirdine—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	6.15e-05	0.00381	CbGpPWpGaD
Delavirdine—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	6.15e-05	0.00381	CbGpPWpGaD
Delavirdine—CYP3A7—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.07e-05	0.00375	CbGpPWpGaD
Delavirdine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	5.76e-05	0.00356	CbGpPWpGaD
Delavirdine—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.41e-05	0.00335	CbGpPWpGaD
Delavirdine—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	4.81e-05	0.00298	CbGpPWpGaD
Delavirdine—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	4.81e-05	0.00298	CbGpPWpGaD
Delavirdine—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	4.75e-05	0.00294	CbGpPWpGaD
Delavirdine—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	4.75e-05	0.00294	CbGpPWpGaD
Delavirdine—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.69e-05	0.0029	CbGpPWpGaD
Delavirdine—CYP3A5—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.39e-05	0.00271	CbGpPWpGaD
Delavirdine—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.18e-05	0.00259	CbGpPWpGaD
Delavirdine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.85e-05	0.00238	CbGpPWpGaD
Delavirdine—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.81e-05	0.00236	CbGpPWpGaD
Delavirdine—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.8e-05	0.00235	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—SRM—multiple sclerosis	3.48e-05	0.00215	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.44e-05	0.00213	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.44e-05	0.00213	CbGpPWpGaD
Delavirdine—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.39e-05	0.0021	CbGpPWpGaD
Delavirdine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	3.35e-05	0.00207	CbGpPWpGaD
Delavirdine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.26e-05	0.00202	CbGpPWpGaD
Delavirdine—CYP3A7—Biological oxidations—POMC—multiple sclerosis	3.22e-05	0.00199	CbGpPWpGaD
Delavirdine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.12e-05	0.00193	CbGpPWpGaD
Delavirdine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.09e-05	0.00191	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.07e-05	0.0019	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.07e-05	0.0019	CbGpPWpGaD
Delavirdine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	2.99e-05	0.00185	CbGpPWpGaD
Delavirdine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	2.98e-05	0.00184	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	2.8e-05	0.00173	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	2.8e-05	0.00173	CbGpPWpGaD
Delavirdine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.64e-05	0.00163	CbGpPWpGaD
Delavirdine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	2.51e-05	0.00156	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—SRM—multiple sclerosis	2.51e-05	0.00155	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—CYP24A1—multiple sclerosis	2.45e-05	0.00152	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—CYP27B1—multiple sclerosis	2.45e-05	0.00152	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	2.4e-05	0.00148	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	2.4e-05	0.00148	CbGpPWpGaD
Delavirdine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	2.33e-05	0.00144	CbGpPWpGaD
Delavirdine—CYP3A5—Biological oxidations—POMC—multiple sclerosis	2.33e-05	0.00144	CbGpPWpGaD
Delavirdine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	2.32e-05	0.00144	CbGpPWpGaD
Delavirdine—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	2.28e-05	0.00141	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—GPC5—multiple sclerosis	2.24e-05	0.00139	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—SRM—multiple sclerosis	2.18e-05	0.00135	CbGpPWpGaD
Delavirdine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	2.17e-05	0.00134	CbGpPWpGaD
Delavirdine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	2.17e-05	0.00134	CbGpPWpGaD
Delavirdine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.04e-05	0.00126	CbGpPWpGaD
Delavirdine—CYP2C8—Biological oxidations—POMC—multiple sclerosis	2.02e-05	0.00125	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—SRM—multiple sclerosis	1.94e-05	0.0012	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—RRM1—multiple sclerosis	1.86e-05	0.00115	CbGpPWpGaD
Delavirdine—CYP2C19—Biological oxidations—POMC—multiple sclerosis	1.8e-05	0.00111	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—SRM—multiple sclerosis	1.79e-05	0.00111	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—SRM—multiple sclerosis	1.77e-05	0.0011	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	1.77e-05	0.0011	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	1.77e-05	0.0011	CbGpPWpGaD
Delavirdine—CYP2D6—Biological oxidations—POMC—multiple sclerosis	1.66e-05	0.00102	CbGpPWpGaD
Delavirdine—CYP2C9—Biological oxidations—POMC—multiple sclerosis	1.64e-05	0.00102	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—GPC5—multiple sclerosis	1.62e-05	0.001	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	1.53e-05	0.000949	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	1.53e-05	0.000949	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—SRM—multiple sclerosis	1.51e-05	0.000937	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.5e-05	0.000927	CbGpPWpGaD
Delavirdine—CYP1A2—Biological oxidations—POMC—multiple sclerosis	1.4e-05	0.000868	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—GPC5—multiple sclerosis	1.4e-05	0.000868	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	1.37e-05	0.000847	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	1.37e-05	0.000847	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—RRM1—multiple sclerosis	1.34e-05	0.00083	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.34e-05	0.000828	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	1.26e-05	0.000779	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	1.26e-05	0.000779	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—GPC5—multiple sclerosis	1.25e-05	0.000775	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	1.25e-05	0.000772	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	1.25e-05	0.000772	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.22e-05	0.000755	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—SRM—multiple sclerosis	1.17e-05	0.000723	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—RRM1—multiple sclerosis	1.16e-05	0.000719	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—GPC5—multiple sclerosis	1.15e-05	0.000712	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—GPC5—multiple sclerosis	1.14e-05	0.000706	CbGpPWpGaD
Delavirdine—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.08e-05	0.00067	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	1.07e-05	0.00066	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	1.07e-05	0.00066	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—BCHE—multiple sclerosis	1.07e-05	0.00066	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.04e-05	0.000645	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—RRM1—multiple sclerosis	1.04e-05	0.000642	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—GPC5—multiple sclerosis	9.76e-06	0.000604	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—RRM1—multiple sclerosis	9.54e-06	0.00059	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—RRM1—multiple sclerosis	9.46e-06	0.000585	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	9.02e-06	0.000558	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	8.23e-06	0.000509	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	8.23e-06	0.000509	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—RRM1—multiple sclerosis	8.08e-06	0.0005	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.05e-06	0.000498	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.75e-06	0.000479	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—BCHE—multiple sclerosis	7.71e-06	0.000477	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—GPC5—multiple sclerosis	7.53e-06	0.000466	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	7.34e-06	0.000454	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	7.06e-06	0.000437	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.92e-06	0.000428	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—BCHE—multiple sclerosis	6.68e-06	0.000413	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—APOE—multiple sclerosis	6.42e-06	0.000397	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.31e-06	0.00039	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.31e-06	0.00039	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	6.27e-06	0.000388	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—RRM1—multiple sclerosis	6.24e-06	0.000386	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—BCHE—multiple sclerosis	5.96e-06	0.000369	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	5.75e-06	0.000356	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—POMC—multiple sclerosis	5.51e-06	0.000341	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—BCHE—multiple sclerosis	5.48e-06	0.000339	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—BCHE—multiple sclerosis	5.43e-06	0.000336	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	5.39e-06	0.000333	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—ALB—multiple sclerosis	5.02e-06	0.000311	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.91e-06	0.000304	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—BCHE—multiple sclerosis	4.64e-06	0.000287	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—APOE—multiple sclerosis	4.64e-06	0.000287	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—APOE—multiple sclerosis	4.02e-06	0.000248	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—POMC—multiple sclerosis	3.98e-06	0.000246	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—ALB—multiple sclerosis	3.63e-06	0.000225	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—APOE—multiple sclerosis	3.59e-06	0.000222	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—BCHE—multiple sclerosis	3.58e-06	0.000222	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—POMC—multiple sclerosis	3.45e-06	0.000213	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—APOE—multiple sclerosis	3.3e-06	0.000204	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—APOE—multiple sclerosis	3.27e-06	0.000202	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—ALB—multiple sclerosis	3.15e-06	0.000195	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—POMC—multiple sclerosis	3.08e-06	0.000191	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—POMC—multiple sclerosis	2.83e-06	0.000175	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—POMC—multiple sclerosis	2.81e-06	0.000174	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—ALB—multiple sclerosis	2.81e-06	0.000174	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—APOE—multiple sclerosis	2.79e-06	0.000173	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—ALB—multiple sclerosis	2.58e-06	0.00016	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—ALB—multiple sclerosis	2.56e-06	0.000158	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—POMC—multiple sclerosis	2.4e-06	0.000148	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—ALB—multiple sclerosis	2.19e-06	0.000135	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—APOE—multiple sclerosis	2.16e-06	0.000133	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—POMC—multiple sclerosis	1.85e-06	0.000115	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—ALB—multiple sclerosis	1.69e-06	0.000104	CbGpPWpGaD
